Informações: Esta não é a versão mais recente do modelo de dados. Uma visão geral da versão pode ser encontrada à esquerda em Versões. Para a versão mais recente, clique aqui.
Informações:
Falhas:
ID
12294
Descrição
An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). NCT00090051 Roche BO17072 FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients
Palavras-chave
Versões (8)
- 31/03/2015 31/03/2015 - Martin Dugas
- 02/04/2015 02/04/2015 - Martin Dugas
- 09/04/2015 09/04/2015 -
- 08/06/2015 08/06/2015 -
- 27/10/2015 27/10/2015 -
- 03/11/2015 03/11/2015 - Julian Varghese
- 03/11/2015 03/11/2015 - Julian Varghese
- 15/03/2021 15/03/2021 - Dr. rer. medic Philipp Neuhaus
Transferido a
3 de novembro de 2015
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
CLL Demographics and Medical History BO17072 NCT00090051
Demographics and Medical History Chronic Lymphocytic Leukemia NCT00090051
Similar models
Demographics and Medical History Chronic Lymphocytic Leukemia NCT00090051
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Visit date
Item
Date of visit
date
C1320303 (UMLS CUI-1)
Patient initials
Item
text
C2986440 (UMLS CUI-1)
Birth Date
Item
Birth Date
date
C0421451 (UMLS CUI-1)
CL Item
male (m)
CL Item
female (f)
CL Item
childbearing potential without contraceptive protection (-> exclusion) (1)
C3831118 (UMLS CUI-1)
C0700589 (UMLS CUI-2)
C0700589 (UMLS CUI-2)
CL Item
childbearing potential with contraceptive protection (-> specify) (2)
C3831118 (UMLS CUI-1)
C0742784 (UMLS CUI-2)
C0742784 (UMLS CUI-2)
CL Item
surgically sterilized (3)
C0015787 (UMLS CUI-1)
CL Item
postmenopausal (4)
C0232970 (UMLS CUI-1)
contraceptive protection, specify
Item
contraceptive protection, specify
text
C0700589 (UMLS CUI [1])
CL Item
caucasian/white (1)
C0007457 (UMLS CUI-1)
CL Item
black (2)
C0005680 (UMLS CUI-1)
CL Item
oriental (3)
C0078988 (UMLS CUI-1)
CL Item
other (specify) (4)
C0205394 (UMLS CUI-1)
Other race
Item
Specify race
text
C0034510 (UMLS CUI [1])
Item Group
Serum pregnancy test (only females of childbearing potential)
C0430060 (UMLS CUI-1)
pregnancy test date
Item
Date of pregnancy test
date
C0430060 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
CL Item
negative (0)
C0205160 (UMLS CUI-1)
CL Item
positive (-> patient must be excluded from study) (1)
C1446409 (UMLS CUI-1)
Item
Are there any diseases (including allergies) that are clinically significant or for which the patient is under treatment (list treatments on treatment form) other than CLL?
integer
C2985739 (UMLS CUI [1])
Code List
Are there any diseases (including allergies) that are clinically significant or for which the patient is under treatment (list treatments on treatment form) other than CLL?
CL Item
yes -> specify (1)
CL Item
no (0)
Disease
Item
Disease
text
C0012634 (UMLS CUI-1)
active
Item
boolean
C0205177 (UMLS CUI-1)
Item
Have there been any previous drug treatments (or medical procedures) not associated with CLL completed in the last month?
integer
C0814462 (UMLS CUI [1])
Code List
Have there been any previous drug treatments (or medical procedures) not associated with CLL completed in the last month?
CL Item
yes (->specify) (1)
C1705108 (UMLS CUI-1)
CL Item
no (0)
C1298908 (UMLS CUI-1)
Treatment
Item
Name of treatment (or medical procedure)
text
C0087111 (UMLS CUI-1)
Item Group
Previous treatments/medical procedures/chemotherapy related to CLL
C0814462 (UMLS CUI-1)
treatment name
Item
Name of treatment
text
C3665472 (UMLS CUI [1])
Start date
Item
Start date
date
C0808070 (UMLS CUI-1)
End date
Item
End date
date
C0806020 (UMLS CUI-1)
CL Item
CR (1)
C0677874 (UMLS CUI-1)
CL Item
PR (2)
C1521726 (UMLS CUI-1)
CL Item
SD (3)
C0677946 (UMLS CUI-1)
CL Item
PD (4)
C1335499 (UMLS CUI-1)
CL Item
NK/NA (5)
C0439673 (UMLS CUI-1)
site of radiotherapy
Item
site of radiotherapy
integer
C1997599 (UMLS CUI [1])
Total dose
Item
Total dose
float
C2986497 (UMLS CUI [1])
Start date
Item
Start date
date
C0808070 (UMLS CUI [1])
End date
Item
End date
date
C0806020 (UMLS CUI [1])
Surgical procedure
Item
Surgical procedure
text
C0543467 (UMLS CUI-1)
Date
Item
Date of Surgery
date
C1628561 (UMLS CUI [1])
Name of treatment
Item
Name of treatment
text
C0087111 (UMLS CUI-1)
Start date
Item
Start date
date
C0808070 (UMLS CUI-1)
End date
Item
End date
date
C0806020 (UMLS CUI-1)